具有潜在VEGFR抑制性质的抗质含有醇的化合物
Dalia R Aboshouk1, M Adel Youssef2, Mohamed S Bekheit1
1Department of Pesticide Chemistry, National Research Centre Dokki Giza 12622 Egypt girgisas10@yahoo.com as.girgis@nrc.sci.eg.
RSC advances
|February 16, 2024
概括
有针对性的癌症疗法显示出希望,重点是抑制血管内皮生长因子受体 (VEGFR). 最近的以醇为基础的化合物通过向VEGFR.显示出作为抗癌剂的巨大潜力.
科学领域:
- 在瘤学瘤学.
- 药用化学 医学化学
- 分子生物学分子生物学
背景情况:
- 癌症仍然是全球主要的健康挑战,晚期癌症往往对当前的治疗方法具有抗性.
- 氨酸激酶的过度表达,特别是血管内皮生长因子受体 (VEGFR),驱动癌症的扩散和血管生成.
- 针对性疗法在减少副作用和提高疗效方面比传统疗法具有优势.
研究的目的:
- 审查最近 (2012-2023) 具有潜在抗癌和VEGFR抑制特性的含印醇化合物.
- 突出有前途的候选药物,天然产品和合成化合物,针对VEGFR.
- 在癌症治疗中探索功能化和螺旋环性醇类似物.
主要方法:
- 2012年至2023年科学出版物的文献综述.
- 识别和总结报告具有抗瘤活性的内类同类的研究.
- 专注于显示血管内皮生长因子受体 (VEGFR) 抑制的化合物.
主要成果:
- 几种醇类似物具有显著的抗癌潜力.
- 针对VEGFR的化合物在临床前研究中显示出有前途.
- 功能化醇,异环合物和螺旋醇是研究的关键领域.
结论:
- 醇衍生物代表了一类有前途的化合物,用于开发向的抗癌疗法.
- 印类同类物抑制VEGFR是一种有效的策略,可以对抗血管生成依赖的癌症.
- 对新型的内结构的持续研究可能会为晚期癌症提供有效的治疗方法.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
163
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
163
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K


